Modulation of human thrombopoietin receptor conformations uncouples JAK2 V617F-driven from cytokine-induced activation
The Thrombopoietin Receptor (TpoR) is a central player in Myeloproliferative Neoplasms (MPNs). Mutations in JAK2, calreticulin or in TpoR itself drive constitutive activation of TpoR and uncontrolled proliferation and differentiation of hematopoietic stem cells and progenitors. The JAK2 V617F mutati...
Main Authors: | Papadopoulos, N, Pristavec, A, Nédélec, A, Levy, G, Staerk, J, Constantinescu, SN |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Hematology
2023
|
Similar Items
-
Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera.
by: Jerry L Spivak, et al.
Published: (2020-01-01) -
Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms
by: Sophie Allain-Maillet, et al.
Published: (2020-08-01) -
JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles
by: Hilal Hekimoğlu, et al.
Published: (2022-02-01) -
A mutação JAK2 V617F e as síndromes mieloproliferativas JAK2 V617F mutation and the myeloproliferative disorders
by: Bárbara C. R. Monte-Mór, et al.
Published: (2008-01-01) -
Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers
by: Defour, J-P, et al.
Published: (2023)